192 related articles for article (PubMed ID: 34662116)
1. Prospective Selective Mechanism of Emerging Senolytic Agents Derived from Flavonoids.
Wang Y; He Y; Rayman MP; Zhang J
J Agric Food Chem; 2021 Oct; 69(42):12418-12423. PubMed ID: 34662116
[TBL] [Abstract][Full Text] [Related]
2. Fisetin is a senotherapeutic that extends health and lifespan.
Yousefzadeh MJ; Zhu Y; McGowan SJ; Angelini L; Fuhrmann-Stroissnigg H; Xu M; Ling YY; Melos KI; Pirtskhalava T; Inman CL; McGuckian C; Wade EA; Kato JI; Grassi D; Wentworth M; Burd CE; Arriaga EA; Ladiges WL; Tchkonia T; Kirkland JL; Robbins PD; Niedernhofer LJ
EBioMedicine; 2018 Oct; 36():18-28. PubMed ID: 30279143
[TBL] [Abstract][Full Text] [Related]
3. Emerging senolytic agents derived from natural products.
Li W; Qin L; Feng R; Hu G; Sun H; He Y; Zhang R
Mech Ageing Dev; 2019 Jul; 181():1-6. PubMed ID: 31077707
[TBL] [Abstract][Full Text] [Related]
4. New agents that target senescent cells: the flavone, fisetin, and the BCL-X
Zhu Y; Doornebal EJ; Pirtskhalava T; Giorgadze N; Wentworth M; Fuhrmann-Stroissnigg H; Niedernhofer LJ; Robbins PD; Tchkonia T; Kirkland JL
Aging (Albany NY); 2017 Mar; 9(3):955-963. PubMed ID: 28273655
[TBL] [Abstract][Full Text] [Related]
5. Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications.
Chandrakar L; Ambatwar R; Khatik GL
Curr Top Med Chem; 2024; 24(2):157-178. PubMed ID: 38037999
[TBL] [Abstract][Full Text] [Related]
6. AMPK-mediated senolytic and senostatic activity of quercetin surface functionalized Fe
Lewinska A; Adamczyk-Grochala J; Bloniarz D; Olszowka J; Kulpa-Greszta M; Litwinienko G; Tomaszewska A; Wnuk M; Pazik R
Redox Biol; 2020 Jan; 28():101337. PubMed ID: 31622846
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors.
Zhu Y; Tchkonia T; Fuhrmann-Stroissnigg H; Dai HM; Ling YY; Stout MB; Pirtskhalava T; Giorgadze N; Johnson KO; Giles CB; Wren JD; Niedernhofer LJ; Robbins PD; Kirkland JL
Aging Cell; 2016 Jun; 15(3):428-35. PubMed ID: 26711051
[TBL] [Abstract][Full Text] [Related]
8. Senolytic drugs: from discovery to translation.
Kirkland JL; Tchkonia T
J Intern Med; 2020 Nov; 288(5):518-536. PubMed ID: 32686219
[TBL] [Abstract][Full Text] [Related]
9. Senolytic targets and new strategies for clearing senescent cells.
Ge M; Hu L; Ao H; Zi M; Kong Q; He Y
Mech Ageing Dev; 2021 Apr; 195():111468. PubMed ID: 33741395
[TBL] [Abstract][Full Text] [Related]
10. Specific Irreversible Cell-Cycle Arrest and Depletion of Cancer Cells Obtained by Combining Curcumin and the Flavonoids Quercetin and Fisetin.
Barra V; Chiavetta RF; Titoli S; Provenzano IM; Carollo PS; Di Leonardo A
Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885908
[No Abstract] [Full Text] [Related]
11. Potential Role of Polyphenolic Flavonoids as Senotherapeutic Agents in Degenerative Diseases and Geroprotection.
Mbara KC; Devnarain N; Owira PMO
Pharmaceut Med; 2022 Dec; 36(6):331-352. PubMed ID: 36100824
[TBL] [Abstract][Full Text] [Related]
12. Sexual dimorphic metabolic and cognitive responses of C57BL/6 mice to Fisetin or Dasatinib and quercetin cocktail oral treatment.
Fang Y; Medina D; Stockwell R; McFadden S; Quinn K; Peck MR; Bartke A; Hascup KN; Hascup ER
Geroscience; 2023 Oct; 45(5):2835-2850. PubMed ID: 37296266
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological Targeting of Senescence with Senolytics as a New Therapeutic Strategy for Neurodegeneration.
Richardson M; Richardson DR
Mol Pharmacol; 2024 Jan; 105(2):64-74. PubMed ID: 38164616
[TBL] [Abstract][Full Text] [Related]
14. Targeted Reduction of Senescent Cell Burden Alleviates Focal Radiotherapy-Related Bone Loss.
Chandra A; Lagnado AB; Farr JN; Monroe DG; Park S; Hachfeld C; Tchkonia T; Kirkland JL; Khosla S; Passos JF; Pignolo RJ
J Bone Miner Res; 2020 Jun; 35(6):1119-1131. PubMed ID: 32023351
[TBL] [Abstract][Full Text] [Related]
15. A study of the molecular mechanism of quercetin and dasatinib combination as senolytic in alleviating age-related and kidney diseases.
Alharbi KS; Afzal O; Altamimi ASA; Almalki WH; Kazmi I; Al-Abbasi FA; Alzarea SI; Makeen HA; Albratty M
J Food Biochem; 2022 Dec; 46(12):e14471. PubMed ID: 36268851
[TBL] [Abstract][Full Text] [Related]
16. Senescence-mediated anticancer effects of quercetin.
Özsoy Gökbilen S; Becer E; Vatansever HS
Nutr Res; 2022 Aug; 104():82-90. PubMed ID: 35635900
[TBL] [Abstract][Full Text] [Related]
17. Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice.
Roos CM; Zhang B; Palmer AK; Ogrodnik MB; Pirtskhalava T; Thalji NM; Hagler M; Jurk D; Smith LA; Casaclang-Verzosa G; Zhu Y; Schafer MJ; Tchkonia T; Kirkland JL; Miller JD
Aging Cell; 2016 Oct; 15(5):973-7. PubMed ID: 26864908
[TBL] [Abstract][Full Text] [Related]
18. Discovery of piperlongumine as a potential novel lead for the development of senolytic agents.
Wang Y; Chang J; Liu X; Zhang X; Zhang S; Zhang X; Zhou D; Zheng G
Aging (Albany NY); 2016 Nov; 8(11):2915-2926. PubMed ID: 27913811
[TBL] [Abstract][Full Text] [Related]
19. Cellular senescence in aging and age-related diseases: Implications for neurodegenerative diseases.
Wissler Gerdes EO; Zhu Y; Weigand BM; Tripathi U; Burns TC; Tchkonia T; Kirkland JL
Int Rev Neurobiol; 2020; 155():203-234. PubMed ID: 32854855
[TBL] [Abstract][Full Text] [Related]
20. Age-associated callus senescent cells produce TGF-β1 that inhibits fracture healing in aged mice.
Liu J; Zhang J; Lin X; Boyce BF; Zhang H; Xing L
J Clin Invest; 2022 Apr; 132(8):. PubMed ID: 35426372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]